These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 10319084)

  • 1. Cardiac production of angiotensin II and its pharmacologic inhibition: effects on the coronary circulation.
    Schmermund A; Lerman LO; Ritman EL; Rumberger JA
    Mayo Clin Proc; 1999 May; 74(5):503-13. PubMed ID: 10319084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart.
    Pörsti I; Hecker M; Bassenge E; Busse R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):650-8. PubMed ID: 7510856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ACE inhibition on neurohormones.
    Remme WJ
    Eur Heart J; 1998 Sep; 19 Suppl J():J16-23. PubMed ID: 9796836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin.
    Needleman P; Marshall GR; Sobel BE
    Circ Res; 1975 Dec; 37(6):802-8. PubMed ID: 1192572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasculoprotective and cardioprotective mechanisms of angiotensin-converting enzyme inhibition: the homeostatic balance between angiotensin II and nitric oxide.
    Gibbons GH
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-18-25. PubMed ID: 9422848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ischaemic effects of converting enzyme inhibitors: underlying mechanisms and future prospects.
    Remme WJ; Bartels GL
    Eur Heart J; 1995 Aug; 16 Suppl I():87-95. PubMed ID: 8829963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endothelium in acute coronary syndromes.
    Noll G; Lüscher TF
    Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional and structural behavior of the cardiovascular system of normotonic and spontaneously hypertensive rats following chemical sympathectomy and angiotensin administration].
    Matthias D; Moritz V; Engler E; Will-Shahab L; Schmidt R; Becker CH
    Acta Biol Med Ger; 1981; 40(12):1745-58. PubMed ID: 6808796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
    Zeiher AM; Schächinger V
    Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration.
    Sun Y; Weber KT
    J Lab Clin Med; 1993 Oct; 122(4):404-11. PubMed ID: 8228554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II and insulin induce growth of ciliary artery smooth muscle: effects of AT1/AT2 antagonists.
    Dubey RK; Flammer J; Lüscher TF
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2067-75. PubMed ID: 9761285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
    Brilla CG; Zhou G; Matsubara L; Weber KT
    J Mol Cell Cardiol; 1994 Jul; 26(7):809-20. PubMed ID: 7966349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics.
    Prosser HC; Forster ME; Richards AM; Pemberton CJ
    Cardiovasc Res; 2009 Apr; 82(1):40-50. PubMed ID: 19147651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotection of ACE inhibitor in ischemic heart is not dependent on the local angiotensin II formation.
    Noda K; Sasaguri M; Ideishi M; Ikeda M; Arakawa K
    Agents Actions Suppl; 1992; 38 ( Pt 3)():217-27. PubMed ID: 1462860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
    Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
    Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.